PUBLISHER: IMARC | PRODUCT CODE: 1370269
PUBLISHER: IMARC | PRODUCT CODE: 1370269
The global embolic protection devices market size reached US$ 1,069 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,706 Million by 2028, exhibiting a growth rate (CAGR) of 8.3% during 2023-2028.
Embolic protection devices (EPD) trap blood and luminal debris within the saphenous vein graft (SVG) during stenting to prevent distal embolization. There are three classes of these devices, including distal occlusion devices, distal filters and proximal occlusion devices. These devices provide the most verified strategy to reduce periprocedural myocardial infarction (MI) and major adverse cardiovascular events by capturing and removing debris that may get dislodged during surgical procedures such as SVG interventions, percutaneous coronary intervention, aortic valve stenosis, etc.
The increasing prevalence of cardiovascular diseases (CVDs) represent one of the key factors driving the market growth. EPDs are crucial in reducing complications arising due to blockages in small blood vessels caused by the debris that is released into the bloodstream. They form a part of the most reliable, evidence-based procedure for reducing periprocedural MI and other major cardiovascular events. This, coupled with increasing instances of cardiac arrests and other heart-related issues, is providing a significant boost to the market for EPDs. Furthermore, governments of several nations across the globe are investing in increasing their research and development (R&D) capabilities, which is acting as another major growth-inducing factor. Steadily increasing geriatric population across the world, which is more susceptible to chronic medical illnesses, is also contributing to the market growth. The rising demand for minimally invasive products and several technological advancements, along with the significant growth in the healthcare sector, are some of the other factors that are expected to further create a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global embolic protection devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application, procedure, material, usage and end-user.
Distal Filter Devices
Distal Occlusion Devices
Proximal Occlusion Devices
Coronary Artery Treatment
Carotid Artery Treatment
Others
Percutaneous Coronary Intervention
Carotid Artery Stenosis
Saphenous Vein Graft Intervention
Aortic Valve Stenosis (Transcatheter Aortic Valve Replacement)
Others
Nitinol
Polyurethane
Disposable Devices
Re-Usable Devices
Hospitals and Clinics
Ambulatory Surgical Centers
Others
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Allium Medical Solutions Ltd., Boston Scientific Corporation, Cardinal Health Inc., Contego Medical LLC, Innovative Cardiovascular Solutions LLC, Edwards Lifesciences Corporation, Medtronic Inc., Silk Road Medical Inc., etc.